西藏诺迪康药业股份有限公司 关于持股5%以上的股东部分股份 解除质押的公告

Core Points - The announcement details the release of pledged shares by a major shareholder, Huaxi Pharmaceutical Group, which holds 56.15 million shares, accounting for 17.42% of the company's total shares [2] - After the release of the pledge, Huaxi Pharmaceutical has a total of 18.76 million shares pledged, representing 33.41% of its holdings and 5.82% of the company's total shares [2] - There are no plans for further pledging of the released shares [2] Summary by Sections - Shareholder Information - Huaxi Pharmaceutical Group is the second-largest shareholder of the company, holding 56.15 million shares [2] - Pledge Details - The release of the pledge has been completed, and the current pledged shares amount to 18.76 million [2] - Future Plans - There are no subsequent plans for pledging the released shares [2]